IL137105A0 - Method for administering aspb28-human insulin - Google Patents

Method for administering aspb28-human insulin

Info

Publication number
IL137105A0
IL137105A0 IL13710599A IL13710599A IL137105A0 IL 137105 A0 IL137105 A0 IL 137105A0 IL 13710599 A IL13710599 A IL 13710599A IL 13710599 A IL13710599 A IL 13710599A IL 137105 A0 IL137105 A0 IL 137105A0
Authority
IL
Israel
Prior art keywords
human insulin
aspb28
administering
administering aspb28
insulin
Prior art date
Application number
IL13710599A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL137105A0 publication Critical patent/IL137105A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
IL13710599A 1998-01-08 1999-01-07 Method for administering aspb28-human insulin IL137105A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7075298P 1998-01-08 1998-01-08
PCT/US1999/000290 WO1999034815A1 (en) 1998-01-08 1999-01-07 Method for administering aspb28-human insulin

Publications (1)

Publication Number Publication Date
IL137105A0 true IL137105A0 (en) 2001-06-14

Family

ID=22097181

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13715099A IL137150A0 (en) 1998-01-08 1999-01-07 Method for administering monomeric insulin analogs
IL13710599A IL137105A0 (en) 1998-01-08 1999-01-07 Method for administering aspb28-human insulin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL13715099A IL137150A0 (en) 1998-01-08 1999-01-07 Method for administering monomeric insulin analogs

Country Status (16)

Country Link
US (2) US20010053761A1 (hu)
EP (2) EP0951911A3 (hu)
JP (2) JP2002500193A (hu)
KR (2) KR20010033941A (hu)
CN (2) CN1287492A (hu)
AU (2) AU754707B2 (hu)
BR (2) BR9906813A (hu)
CA (2) CA2317733A1 (hu)
EA (2) EA200000747A1 (hu)
HU (2) HUP0100391A3 (hu)
IL (2) IL137150A0 (hu)
NO (2) NO20003051L (hu)
PL (2) PL341592A1 (hu)
TR (2) TR200001892T2 (hu)
WO (2) WO1999034816A1 (hu)
ZA (2) ZA99105B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
WO2002043580A2 (en) 2000-10-27 2002-06-06 Epic Therapeutics, Inc. Production of microspheres
EP1944016A1 (en) 2001-08-16 2008-07-16 Baxter International Inc. Propellant-based microparticle formulatons
DE60226613D1 (de) * 2001-08-16 2008-06-26 Baxter Int Darreichungsformen welche mikropartikel und treibgas enthalten
CA2466525C (en) * 2001-12-07 2011-05-17 Eiffel Technologies Limited Synthesis of small particles
US20050107441A1 (en) * 2001-12-21 2005-05-19 Kliewer Steven A. Compositions and methods for altering glucose production
US7677411B2 (en) 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6985798B2 (en) * 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
SI1534366T1 (sl) * 2002-06-27 2014-04-30 Oriel Therapeutics, Inc. Sistem za polnjenje doze s suhim praškom in ustrezni postopek
US7451761B2 (en) * 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
WO2005041848A2 (en) 2003-10-27 2005-05-12 Oriel Therapeutics, Inc. Dry powder drug containment system packages with tabs, inhalers and associated methods
WO2005065756A2 (en) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en) 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
US8365725B2 (en) * 2004-09-13 2013-02-05 Oriel Therapeutics, Inc. Dry powder inhalers that inhibit agglomeration, related devices and methods
US8327843B2 (en) * 2005-08-25 2012-12-11 Oriel Therapeutics, Inc. Drug containment systems with sticks, related kits, dry powder inhalers and methods
US7987845B2 (en) * 2006-01-31 2011-08-02 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
EP2346554B1 (en) 2008-09-26 2015-09-16 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
MX2011003244A (es) 2008-09-26 2011-04-28 Oriel Therapeutics Inc Inhaladores con discos de vias aereas con canales de vias aereas discretas y discos y metodos relacionados.
MX2011003233A (es) 2008-09-26 2011-04-28 Oriel Therapeutics Inc Inhaladores de polvo seco con miembros de perforacion doble y dispositivos y metodos relacionados.
WO2010039200A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods
WO2010039201A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
CA2732827C (en) * 2008-10-01 2016-10-11 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
JP5341532B2 (ja) * 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
WO2011080747A2 (en) 2010-01-27 2011-07-07 Aespira Ltd. Dry powder inhaler
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
ES2130428T3 (es) * 1993-06-21 1999-07-01 Novo Nordisk As Cristales de insulina asp-b28.
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
IL118127A0 (en) * 1995-05-05 1996-09-12 Lilly Co Eli Single chain insulin with high bioactivity

Also Published As

Publication number Publication date
AU754707B2 (en) 2002-11-21
CA2317733A1 (en) 1999-07-15
NO20003050L (no) 2000-06-14
PL342745A1 (en) 2001-07-02
AU747619B2 (en) 2002-05-16
EP0951911A2 (en) 1999-10-27
EP0951910A3 (en) 2002-06-19
HUP0100391A3 (en) 2001-12-28
PL341592A1 (en) 2001-04-23
EA200000748A1 (ru) 2000-12-25
EP0951910A2 (en) 1999-10-27
EP0951911A3 (en) 2002-06-19
JP2002500192A (ja) 2002-01-08
HUP0100391A2 (hu) 2001-08-28
JP2002500193A (ja) 2002-01-08
EA200000747A1 (ru) 2000-12-25
US20010007853A1 (en) 2001-07-12
US20010053761A1 (en) 2001-12-20
KR20010033940A (ko) 2001-04-25
AU2312299A (en) 1999-07-26
HUP0101293A3 (en) 2001-12-28
NO20003051D0 (no) 2000-06-14
CN1287492A (zh) 2001-03-14
TR200001892T2 (tr) 2000-11-21
BR9906813A (pt) 2001-03-20
NO20003050D0 (no) 2000-06-14
WO1999034816A1 (en) 1999-07-15
AU2107399A (en) 1999-07-26
WO1999034815A1 (en) 1999-07-15
NO20003051L (no) 2000-06-14
ZA99104B (en) 2000-07-07
CA2317739A1 (en) 1999-07-15
CN1195543C (zh) 2005-04-06
KR20010033941A (ko) 2001-04-25
ZA99105B (en) 2000-07-07
CN1287491A (zh) 2001-03-14
BR9906796A (pt) 2000-11-14
HUP0101293A2 (hu) 2001-08-28
IL137150A0 (en) 2001-07-24
TR200001891T2 (tr) 2000-11-21

Similar Documents

Publication Publication Date Title
IL137105A0 (en) Method for administering aspb28-human insulin
ZA989744B (en) Method for administering acylated insulin.
IL141241A0 (en) Method for administering insulinotropic peptides
AU5175999A (en) Anesthetic injection apparatus
AU3600699A (en) Method for regulating insulin medication
HUP0003920A2 (en) An injection syringe
HUP0002127A3 (en) Syringe
PL334627A1 (en) System for making hypodermal injections
HUP0200556A2 (en) Medicament for treating diabetes
EP0979660A4 (en) SYRINGE
ZA99283B (en) Inhaler for medication.
PL340503A1 (en) Apparatus for administering fluids
EP1121950A4 (en) MEDICATION INJECTOR
IL136878A0 (en) Method for inhaling powdery substances
EP0689052A3 (en) Standard insulin solution
GB9700789D0 (en) Syringe
HUP0103569A3 (en) New medicament and process for its preparation
GB9712462D0 (en) Dental syringe assemblies
GB9827865D0 (en) Medicament
AU136934S (en) Infusion apparatus
TW571751U (en) Safe syringe
EP1192243A4 (en) METHOD FOR REINFORCING HEMATOPOIESE
TW355367U (en) Structure for safety syringe
GB9816285D0 (en) Hypodermic syringe
AU6101899A (en) Means for preventing needlestick injuries